Earth Science Tech, Inc. (ETST) reported its financial results for the three and six months ended September 30, 2025, revealing a revenue increase to $9.05 million for the third quarter, up from $8.52 million in the same period last year. For the first half of the fiscal year, revenue reached $17.81 million, compared to $17.09 million in the prior year. The company achieved a gross profit of $6.72 million for the third quarter, reflecting a gross margin of approximately 74.2%, which is an increase from $6.27 million in the previous year. Net income for the quarter was reported at $945,897, compared to $798,368 in the same quarter of 2024, indicating a year-over-year increase in profitability.
The company experienced significant changes in its financial position compared to the previous fiscal period. Total assets increased to $8.67 million as of September 30, 2025, up from $7.07 million at the end of March 2025. This growth was primarily driven by an increase in inventory, which rose to $1.04 million from $503,938, and equity investments at fair value, which increased to $989,765 from $645,438. However, total liabilities also rose to $3.59 million from $3.22 million, largely due to an increase in accounts payable, which more than doubled to $1.05 million.
Strategically, ETST has made notable developments, including the acquisition of Mister Meds, a compounding pharmacy, which received full licensure in March 2025. This acquisition is part of ETST's broader strategy to expand its healthcare services through its subsidiaries, which include RxCompound and Peaks Curative. The company is actively pursuing licensure in additional states to enhance its telemedicine offerings and pharmacy services. Additionally, ETST has initiated a $5 million share repurchase program, reflecting its commitment to returning value to shareholders.
Operationally, ETST reported an increase in customer engagement, with a notable rise in advertising and marketing expenses to $740,026 for the third quarter, compared to $152,520 in the same period last year. This investment aims to boost product adoption rates and expand market share. The company’s employee headcount has also increased, reflecting its growth and operational expansion. As of September 30, 2025, the company continues to focus on enhancing its service offerings and geographic reach, particularly in the healthcare sector.
Looking ahead, ETST remains optimistic about its growth trajectory, emphasizing its commitment to operational optimization and strategic acquisitions. The company plans to continue expanding its pharmacy and telemedicine services while managing costs effectively. Management believes that the ongoing investments in marketing and infrastructure will support future revenue growth and profitability, positioning ETST favorably in the competitive landscape of healthcare and pharmaceuticals.
About Earth Science Tech, Inc.
Earth Science Tech, Inc. is a diversified holding company specializing in pharmaceutical compounding, telemedicine, and real estate development. Its subsidiaries include licensed pharmacies, telehealth platforms, and real estate assets, serving healthcare providers and consumers. The company emphasizes operational efficiency, strategic acquisitions, and brand growth in regulated markets, offering customized health solutions, consumer products, and community support through its integrated business model.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.